Coyote Pharmaceuticals Contact Us home About Coyote Technology Therapeutic Focus Partnering News and Publications News & Publications News & Media Coyote Pharmaceuticals Initiates GMP Manufacturing Process for CNS-102 Following Successful Pre-IND Meeting Coyote Cleared to Pursue Fast Track D...

Coyote Pharmaceuticals Contact Us home About Coyote Technology Therapeutic Focus Partnering News and Publications Therapeutic Focus Overview Coyote is developing its heat shock protein technology platform as a potential treatment for a number of degenerative diseases characterized by protein misfold...

Coyote Pharmaceuticals Contact Us home About Coyote Technology Therapeutic Focus Partnering News and Publications About Us Senior Management Hiroaki Serizawa, Ph.D. - President, CEO, and Co-Founder Dr. Serizawa co-founded Coyote Pharmaceuticals in 2009.Previously, he was the CEO of TOR U.S.A. Ventur...

Coyote Pharmaceuticals Contact Us home About Coyote Technology Therapeutic Focus Partnering News and Publications Therapeutic Focus Parkinson's Disease Parkinson's disease is a progressive disorder of the nervous system that affects movement and motor control. It develops gradually, sometimes starti...

Coyote Pharmaceuticals Contact Us home About Coyote Technology Therapeutic Focus Partnering News and Publications News & Publications News & Media Feb 13 2013 Coyote Pharmaceuticals Initiates GMP Manufacturing Process for CNS-102 Following Successful Pre-IND Meeting Jan 2 2013 Coyote Pharmac...